{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:01:30Z","timestamp":1761606090813,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jchromb.2019.05.011","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T21:27:56Z","timestamp":1557869276000},"page":"82-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["An ultra-performance liquid chromatography-tandem mass spectrometry method for the determination of obeticholic acid in rat plasma and its application in preclinical pharmacokinetic studies"],"prefix":"10.1016","volume":"1121","author":[{"given":"Xiang-yu","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-hong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-xin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-jing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jchromb.2019.05.011_bb0005","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/hep.22042","article-title":"The causes of primary biliary cirrhosis: convenient and inconvenient truths","volume":"47","author":"Gershwin","year":"2008","journal-title":"Hepatology"},{"issue":"1 Suppl","key":"10.1016\/j.jchromb.2019.05.011_bb0010","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","article-title":"New paradigms in the treatment of hepatic cholestasis: from udca to fxr, pxr and beyond","volume":"62","author":"Beuers","year":"2015","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.jchromb.2019.05.011_bb0015","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1055\/s-0034-1383733","article-title":"Old and novel therapies for primary biliary cirrhosis","volume":"34","author":"Pares","year":"2014","journal-title":"Semin. Liver Dis."},{"issue":"2","key":"10.1016\/j.jchromb.2019.05.011_bb0020","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1053\/j.gastro.2004.05.005","article-title":"Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment","volume":"127","author":"Selmi","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jchromb.2019.05.011_bb0025","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-pathol-020712-164014","article-title":"The immunobiology and pathophysiology of primary biliary cirrhosis","volume":"8","author":"Hirschfield","year":"2013","journal-title":"Annu. Rev. Pathol."},{"issue":"3","key":"10.1016\/j.jchromb.2019.05.011_bb0030","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","article-title":"Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid","volume":"130","author":"Pares","year":"2006","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jchromb.2019.05.011_bb0035","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22428","article-title":"Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis","volume":"48","author":"Corpechot","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jchromb.2019.05.011_bb0040","doi-asserted-by":"crossref","first-page":"d176","DOI":"10.2741\/A273","article-title":"Regulation of bile acid synthesis","author":"Chiang","year":"1998","journal-title":"Front Biosci"},{"issue":"5418","key":"10.1016\/j.jchromb.2019.05.011_bb0045","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.jchromb.2019.05.011_bb0050","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1097-2765(00)80348-2","article-title":"Endogenous bile acids are ligands for the nuclear receptor fxr\/bar","volume":"3","author":"Wang","year":"1999","journal-title":"Mol. Cell"},{"issue":"10","key":"10.1016\/j.jchromb.2019.05.011_bb0055","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1073\/pnas.0400046101","article-title":"Expression and activation of the farnesoid x receptor in the vasculature","volume":"101","author":"Bishop-Bailey","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.jchromb.2019.05.011_bb0060","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1073\/pnas.1524890113","article-title":"Obeticholic acid, a synthetic bile acid agonist of the farnesoid x receptor, attenuates experimental autoimmune encephalomyelitis","volume":"113","author":"Ho","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.jchromb.2019.05.011_bb0065","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"American Association for Study of Liver D: primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jchromb.2019.05.011_bb0070","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/hep.29569","article-title":"A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis","volume":"67","author":"Kowdley","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jchromb.2019.05.011_bb0075","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2147\/HMER.S91709","article-title":"Obeticholic acid for the treatment of primary biliary cholangitis in adult patients: clinical utility and patient selection","volume":"8","author":"Bowlus","year":"2016","journal-title":"Hepatic medicine: evidence and research"},{"issue":"1","key":"10.1016\/j.jchromb.2019.05.011_bb0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1586\/17474124.2016.1095088","article-title":"The management of autoimmunity in patients with cholestatic liver diseases","volume":"10","author":"Ali","year":"2016","journal-title":"Expert review of gastroenterology & hepatology"},{"issue":"5","key":"10.1016\/j.jchromb.2019.05.011_bb0085","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1517\/14656566.2015.998650","article-title":"Advances in pharmacotherapy for primary biliary cirrhosis","volume":"16","author":"Mousa","year":"2015","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.jchromb.2019.05.011_bb0090","unstructured":"U.S. Food and Drug Administration. FDA Drug Safety Communication: FDA warns about serious liver injury with Ocaliva (obeticholic acid) for rare chronic liver disease. https:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm576656.htm"},{"key":"10.1016\/j.jchromb.2019.05.011_bb0095","unstructured":"U.S. Food and Drug Administration. FDA Drug Safety Communication: FDA adds Boxed Warning to highlight correct dosing of Ocaliva (obeticholic acid) for patients with a rare chronic liver disease. https:\/\/www.fda.gov\/Drugs\/DrugSafety\/DrugSafetyPodcasts\/Ucm595843.htm"},{"issue":"9","key":"10.1016\/j.jchromb.2019.05.011_bb0100","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1007\/s12325-017-0601-0","article-title":"Assessment of pharmacokinetic interactions between obeticholic acid and caffeine, midazolam, warfarin, dextromethorphan, omeprazole, rosuvastatin, and digoxin in phase 1 studies in healthy subjects","volume":"34","author":"Edwards","year":"2017","journal-title":"Adv. Ther."},{"issue":"1","key":"10.1016\/j.jchromb.2019.05.011_bb0105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1124\/jpet.114.214650","article-title":"Semisynthetic bile acid fxr and tgr5 agonists: physicochemical properties, pharmacokinetics, and metabolism in the rat","volume":"350","author":"Roda","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"year":"2001","series-title":"Guidance for Industry: Bioanalytical Method Validation","author":"US DHHS","key":"10.1016\/j.jchromb.2019.05.011_bb0110"},{"key":"10.1016\/j.jchromb.2019.05.011_bb0115","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jchromb.2015.03.025","article-title":"Determination of n-methylcytisine in rat plasma by uplc-ms\/ms and its application to pharmacokinetic study","volume":"990","author":"Wang","year":"2015","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2019.05.011_bb0120","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jpba.2017.11.018","article-title":"Hplc\/uv\/ms method application for the separation of obeticholic acid and its related compounds in development process and quality control","volume":"149","author":"Dousa","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"5","key":"10.1016\/j.jchromb.2019.05.011_bb0125","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2165\/00003088-199630050-00002","article-title":"Clinical pharmacokinetics of therapeutic bile acids","volume":"30","author":"Crosignani","year":"1996","journal-title":"Clin. Pharmacokinet."},{"issue":"11","key":"10.1016\/j.jchromb.2019.05.011_bb0130","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00228-011-1070-z","article-title":"No significant effect of the slco1b1 polymorphism on the pharmacokinetics of ursodeoxycholic acid","volume":"67","author":"Xiang","year":"2011","journal-title":"Eur. J. Clin. Pharmacol."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023219303393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023219303393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T22:57:54Z","timestamp":1761605874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023219303393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":26,"alternative-id":["S1570023219303393"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2019.05.011","relation":{},"ISSN":["1570-0232"],"issn-type":[{"type":"print","value":"1570-0232"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An ultra-performance liquid chromatography-tandem mass spectrometry method for the determination of obeticholic acid in rat plasma and its application in preclinical pharmacokinetic studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2019.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}